The Trump administration is taking its first concrete steps to address the high cost of prescription medications,narrowly focusing on a measure it could assume to increase the competition for former, off-patent drugs. Food and Drug Administration Commissioner Scott Gottlieb announced in a blog post on Wednesday that his agency was crafting a “drug competition action map” to […]
Source: washingtonpost.com